This section provides information and updates regarding implementation of the Medicare Prescription Drug Benefit, and other policy clarifications relating to PACE. Often this information is time-sensitive. CMS recommends that those interested in keeping abreast of current information periodically check this section for new material. ______________________________________________________________________ March 17, 2005 GuidanceAs you know, on March 4, 2005 CMS released the draft PACE Part D application, pending approval of the Office of Management and Budget (OMB). Since the release of this document, we have identified the need for one addition to the original application relating to Part D records retention. The timeframe specified in section 460.200(f) of the PACE regulation relating to records retention varies from the requirement in section 423.505(d) of the Medicare Prescription Drug Benefit final regulation. The CMS has not waived section 423.505(d) of the Prescription drug rule. As a result, for purposes of Part D related records, PACE organizations will be required to adhere to section 423.505(d) by maintaining records for a period of 10 years. In order to capture this requirement, we have attached a records retention attestation form that will need to be submitted with the PACE Part D application. PACE organizations may simply attach this addendum to their March 4, 2005 version of the application. (Please note that the March 4, 2005 version of the application was posted on the CMS website on March 9, 2005, which is the date appearing on the first page of the application.) We have also received a number of questions concerning Appendix II of the application titled "Certification of Monthly Enrollment and Payment Data Relating to CMS Payment to a PACE Organization". For purposes of clarification, this document need not be included with the submission of the application. Rather, this document shall be completed by PACE organizations on a monthly basis after reviewing the CMS Monthly Membership Report (MMR), beginning in 2006. These forms must be mailed to the following address: Integriguard 2121 North 117 Avenue, Suite 200 Omaha, NE 68164 Finally, we have received several questions concerning the Business Integrity requirements relating to both the January 21, 2005 guidance to PACE organizations, Enclosure B titled "PACE Business Integrity" and the Business Integrity requirements outlined in the PACE Part D application. We wish to clarify that CMS will accept a completed Part D application as meeting all Part D Business Integrity requirements. Once again, thank you for your assistance and cooperation throughout this process of transitioning to Part D. _________________________________________________________________ The documents available for downloading fall into two categories: Information regarding the Medicare Prescription Drug Benefit, and information regarding other PACE policy clarifications. The following documents relate to the Medicare Prescription Drug Benefit: - PACE/Part D Implementation Timeframe
- 2006 PACE/Part D Application
- Addendum to Part D Application
- Part D Bid Submission Deadline Waiver Guidance
- Part D Bid Submission Deadline Waiver Form
- 2007 PACE/Part D Application
The following documents relate to other PACE policy clarifications: - CMS Policy for Sentinel Event Reporting
- CMS Policy on PACE Coverage Outside the U.S.
- CMS Policy on Notification of Alternative Care Settings
- Notice for Solicitation of Proposals for For-Profit PACE Demonstrations
New, the week of June 12, 2006, is the solicitation for the Rural PACE Grant Program.
Page Last Modified: 12/14/2005 12:00:00 AM
Help with File Formats and Plug-Ins
Submit Feedback
|